Table 2.
Con | MLP-null | |
---|---|---|
Myofibrillar function | ||
Active tension (mN mm−2) | 39 ± 3 | 18 ± 1** |
Resting tension (mN mm−2) | 2.6 ± 0.4 | 3.1 ± 0.3 |
pCa50 | 5.71 ± 0.02 | 5.67 ± 0.01 |
pATP50 | 3.24 ± 0.04 | 3.29 ± 0.04 |
Mitochondrial function | ||
V0 (μmol O2 min−1 (g dry wt−1)) | 6.0 ± 0.4 | 4.3 ± 0.2* |
Vmax (μmol O2 min−1 (g dry wt−1)) | 22.5 ± 1.1 | 23.3 ± 1.0 |
Acceptor control ratio | 3.9 ± 0.3 | 5.8 ± 0.3** |
Apparent Km(ADP) | 270 ± 34 | 175 ± 15* |
Enzyme activities | ||
Total CK (IU (g protein)−1) | 4226 ± 385 | 3134 ± 365 |
CS (IU (g protein)−1) | 942 ± 112 | 923 ± 67 |
Complex I (IU (g protein)−1) | 933 ± 47 | 898 ± 88 |
P < 0.05
P < 0.005 versus Control. pCa50, (pCa for half-maximal active tension); pATP50, (pATP for half-maximal rigor tension); CK, creatine kinase; CS, citrate synthase.